Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Aptiom (eslicarbazepine acetate)
pCPA File Number:
20853
Negotiation Status:
Concluded with an LOI
Indication(s):
Epilepsy, partial-onset seizures
Sponsor/Manufacturer:
Sunovion Pharmaceuticals Canada Inc.
CADTH Project Number:
SR0391
pCPA Engagement Letter Issued:
2015-06-15
Negotiation Process Concluded:
2015-09-08